Akcea Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Akcea Therapeutics, Inc. reported Basic Shares Outstanding (Weighted Average) of 46.01 million shares for the 12-month period ending 2017-12-31, per its 8-K filed 2018-09-18.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2019-03-01
- Akcea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2017-12-31 was 66.77M shares, a 131.15% increase year-over-year.
- Akcea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2017-09-30 was 59.17M shares, a 104.86% increase year-over-year.
- Akcea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2016-12-31 was 28.88M shares.
- Akcea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2016-09-30 was 28.88M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2017-12-31 | 66.77M shares derived: 8-K 12 month − 10-Q 9 month · filed 2018-09-18 | 62.97M shares derived: average of 2 quarters · filed 2019-03-01 | 46.01M shares 8-K · filed 2018-09-18 | |
| 2017-09-30 | 59.17M shares 10-K · filed 2019-03-01 | 39.09M shares 10-Q · filed 2017-11-07 | ||
| 2016-12-31 | 28.88M shares derived: 8-K 12 month − 10-Q 9 month · filed 2018-09-18 | 28.88M shares derived: average of 2 quarters · filed 2018-09-18 | 28.88M shares 8-K · filed 2018-09-18 | |
| 2016-09-30 | 28.88M shares 10-Q · filed 2017-11-07 | 28.88M shares 10-Q · filed 2017-11-07 | ||
| 2015-12-31 | 28.88M shares 8-K · filed 2018-09-18 |